Panion
  • Home
  • Our Story
    • History
    • Board
  • Science
    • Epilepsy in dogs
    • About Gene therapy
    • About NPY and AAV vectors
  • News
  • Investor relations
Select Page

New CFO in Panion, Sofia Josephson

Dec 29, 2017

Read more >>

Panion’s epilepsy product classified as MUMS in EU for dogs and cats

Dec 11, 2017

Read more >>

Panion’s epilepsy drug candidate shows positive initial results in a long-term study by CombiGene

Dec 7, 2017

Panion Animal Health AB develops a new epilepsy medicine for dogs based on CombiGene’s drug vector CG01. Initial results from CombiGene’s long-term study in rats was released yesterday in a message, which is highly relevant for Panion’s development of the product for...

Panion will not renew Letter of Intent with GeneQuine

Dec 5, 2017

Read more >>

Archives

  • April 2020
  • March 2020
  • February 2020
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • June 2016
  • May 2016
  • February 2016
  • August 2015
  • July 2015

Panion Animal Health AB

org. nr. 559018-4171

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read more